Supergen (SUPG ) granted MGI Pharmaceuticals (MGON ) exclusive worldwide rights to develop, manufacture, and distribute Supergen's anti-cancer drug Dacogen. MGI will make a $40 million equity investment in Supergen. First Boston upgraded Supergen to buy.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Smartphones Are Killing Americans, But Nobody’s Counting
- Why a Pub in the Middle of Nowhere Was Named the World’s Best Restaurant
- Gulf Coast Oil Spill May Be Largest Since 2010 BP Disaster
- Marc Faber Asked to Leave Sprott Board After Racist Report
- Airbus Snaps Up Bombardier Jet in New Challenge to Boeing